CHRO (Chromocell) Rega marang bathi mangsa ngarep
Chromocell Therapeutics (CHRO) is developing a portfolio of non-opioid treatments to manage various types of pain. This chart of the issuer's forward P/E provided by GURU.Markets confirms market expectations, where the 0.00 metric reflects current dynamics. Management is focusing on a niche strategy of qualitative trials, yet the high concentration of resources on ion channels creates significant binary vulnerability for the entire long-term model.
Ringkesan rincian data analitis Chromocell (CHRO)
- kuotasi lan prakiraan analis:
- indikator valuasi pasar bisnis:
- data ekuitas miturut neraca:
- indikator beban utang lan likuiditas:
Utang marang Ekuitas Chromocell Therapeutics|CHRO - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang modal Chromocell Therapeutics|CHRO - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Chromocell Therapeutics Corp|CHRO - Utang jangka dawa|Utang jangka cendhak perusahaan Chromocell Therapeutics|Likuiditas cepet chromocell.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
CHRO - Bathi resik perusahaan|Bathi mangsa ngarep Chromocell Therapeutics|CHRO - Nilai perusahaan marang bathi resik|Prakiraan rega marang bathi Chromocell Therapeutics Corporation|CHRO - Rasio nilai perusahaan marang wutah bathi|Pangali EV/EBITDA Chromocell Therapeutics Corp|CHRO - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) Chromocell Therapeutics|CHRO - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan chromocell.com|CHRO - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Chromocell Therapeutics
Analisis fundamental perusahaan:Chromocell Therapeutics Corp.
For long-term planning, the investor evaluates the value of Chromocell Therapeutics (CHRO) shares through the ratio of current price to expected earnings, as reflected in the company's consensus P/E forecast. This multiple measures market expectations for future income, while the stability of the biomedical sector and its neutral geopolitical status minimize valuation volatility risks, confirming the fundamental resilience of the business.
Pesaing Chromocell Therapeutics (CHRO)
Pangali Forward P/E BIIB|NBIX (Neurocrine) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Regencell RGC|Pangali mangsa ngarep rega marang bathi AXSM|ACAD - Rega marang bathi mangsa ngarep|Rasio prakiraan rega marang bathi xenon-pharma.com|Viking Therapeutics, Inc. (VKTX) - Rega marang bathi mangsa ngarep|Prakiraan rega marang bathi Supernus Pharmaceuticals, Inc.|Rega marang bathi mangsa ngarep Catalyst Pharmaceuticals Inc|Rasio prakiraan rega marang bathi Denali Corp DNLI|Pangali Forward P/E HRMY|Prakiraan rega marang bathi biohavenpharma.com BHVN|Pangali Forward P/E AMLX (Amylyx Pharmaceuticals, Inc.)|Trevi Therapeutics Inc (TRVI) - Rasio prakiraan rega marang bathi|PRAX - Rega marang bathi mangsa ngarep|AVXL: Rega marang bathi mangsa ngarep|CeriBell, Inc. (CBLL) - Rega marang bathi mangsa ngarep|PRTA (Prothena) - Rega marang bathi mangsa ngarep|Prakiraan rega marang bathi ALEC|ANNX: Pangali mangsa ngarep rega marang bathi|Prakiraan rega marang bathi OMER (Omeros Corporation)|Rasio kapitalisasi marang bathi mangsa ngarep NGNE|Pangali Forward P/E ACIU (AC Immune)|Pangali mangsa ngarep rega marang bathi VYGR|Neumora Therapeutics, Inc. - Pangali Forward P/E|Rasio prakiraan rega marang bathi Scilex Holding|Tevogen Bio Holdings, Inc. (TVGN) - Rega marang bathi mangsa ngarep|Alpha Cognition Inc. - Pangali mangsa ngarep rega marang bathi|CGTX (Cognition Therapeutics) - Pangali Forward P/E|Pangali Forward P/E inhibikase.com|Rega marang bathi mangsa ngarep Cassava Sciences (SAVA)|ASRT: Rasio rega marang bathi sing dikarepake|Pangali Forward P/E COYA (Coya Therapeutics)|VistaGen Therapeutics, Inc. (VTGN) - Rasio prakiraan rega marang bathi|OVID: Prakiraan rega marang bathi|ABOS - Pangali Forward P/E|CRVO (CervoMed) - Prakiraan rega marang bathi|ATHE: Rasio kapitalisasi marang bathi mangsa ngarep|CLNN (Clene Inc) - Pangali Forward P/E|PepGen Corp (PEPG) - Kapitalisasi marang proyeksi bathi|Pangali Forward P/E JUNS|Prakiraan rega marang bathi relmada.com RLMD|Rega marang bathi mangsa ngarep Annovis Bio ANVS|Kapitalisasi marang proyeksi bathi Grace Therapeutics Inc (GRCE)|Firefly Neuroscience Inc - Pangali Forward P/E|Klotho Neurosciences Inc (KLTO) - Prakiraan rega marang bathi|NRSN: Pangali Forward P/E|revivapharma.com - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep MetaVia Inc.|NRXS: Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Helius Medical (HSDT)|PASG - Rasio prakiraan rega marang bathi|Rega marang bathi mangsa ngarep Neuphoria Therapeutics NEUP|NERV: Rasio rega marang bathi mangsa ngarep|Athira Pharma - Pangali Forward P/E|Rasio prakiraan rega marang bathi Addex Therapeutics Ltd.|ALZN (alzamend.com) - Prakiraan rega marang bathi|Cyclerion Therapeutics, Inc. (CYCN) - Pangali Forward P/E|Rega marang bathi mangsa ngarep Protagenic Therapeutics Inc.|KTTA: Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Cortigent, Inc. (CRGT)|ATXI - Rasio prakiraan rega marang bathi|Pangali Forward P/E BCLI (Brainstorm Cell Therapeutics, Inc.)|CARA - Prakiraan rega marang bathi|Eliem - Pangali Forward P/E|Pangali mangsa ngarep rega marang bathi ITCI (Intra-Cellular Therapies)|Longboard Pharmaceuticals, Inc. (LBPH) - Rega marang bathi mangsa ngarep|Marinus Pharmaceuticals Inc - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep NKGen|Rasio prakiraan rega marang bathi NeuroBo Pharma NRBO|Rega marang bathi mangsa ngarep Sage Therapeutics, Inc. (SAGE)|Prakiraan rega marang bathi synaptogen.com SNPX|Rega marang bathi mangsa ngarep Trevena TRVN|Vigil Neuroscience Inc. (VIGL) - Rasio prakiraan rega marang bathi|Anew Medical - Pangali Forward P/E|Cerevel Corp (CERE) - Prakiraan rega marang bathi
